Publicacións (27) Publicacións de Alicia Abalo Piñeiro

2023

  1. Clinicopathological Profiles Associated with Discordant RAS Mutational Status between Liquid and Tissue Biopsies in a Real-World Cohort of Metastatic Colorectal Cancer

    Cancers, Vol. 15, Núm. 14

  2. Noninvasive detection of microsatellite instability in patients with endometrial cancer

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217

  3. Rapid Idylla mutational testing to detect EGFR mutations in plasma samples and to monitor therapy in advanced non-small cell lung cancer patients

    Pathology

2022

  1. Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

  2. Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study

    Journal of Oral Pathology and Medicine, Vol. 51, Núm. 5, pp. 429-435

  3. Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients

    Translational Lung Cancer Research, Vol. 11, Núm. 10, pp. 1995-2009

2021

  1. Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab

    Molecular Oncology, Vol. 15, Núm. 11, pp. 2923-2940

  2. Haemodynamic-dependent arrest of circulating tumour cells at large blood vessel bifurcations as new model for metastasis

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Analysis of a real-world cohort of metastatic breast cancer patients shows circulating tumor cell clusters (Ctc-clusters) as predictors of patient outcomes

    Cancers, Vol. 12, Núm. 5

  2. Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer

    Cells, Vol. 9, Núm. 5

  3. Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: A prospective phase II study

    Radiation Oncology, Vol. 15, Núm. 1

  4. Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients

    Cells, Vol. 9, Núm. 2

  5. Genomic profiling of uterine aspirates and cfDNA as an integrative liquid biopsy strategy in endometrial cancer

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  6. Global gene expression characterization of circulating tumor cells in metastasic castration-resistant prostate cancer patients

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-14

  7. Looking for a better characterization of triple-negative breast cancer by means of circulating tumor cells

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. A novel saliva-based mirna signature for colorectal cancer diagnosis

    Journal of Clinical Medicine, Vol. 8, Núm. 12

  2. CTCs expression profiling for advanced breast cancer monitoring

    Cancers, Vol. 11, Núm. 12

  3. Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer

    Cancers, Vol. 11, Núm. 12

  4. Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer

    Journal of Proteome Research, Vol. 18, Núm. 3, pp. 1043-1053

2017

  1. Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients

    Oncotarget, Vol. 8, Núm. 33, pp. 54708-54721